Inhaled pulmonary vasodilators (nitric oxide / prostacyclin)
Respiratory / RV · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Inhaled nitric oxide or nebulised prostacyclin analogues selectively dilate pulmonary vessels in ventilated lung, improving oxygenation and lowering pulmonary artery pressure without systemic hypotension. Used as rescue therapy in refractory hypoxaemia and acute right-ventricular failure.
Red flags
- Abrupt withdrawal causing rebound pulmonary hypertension and desaturation
- Methaemoglobinaemia / nitrogen-dioxide toxicity with nitric oxide
- Systemic hypotension or bleeding with prostacyclin
Assessment
Investigations
- Oxygenation (PaO2/FiO2) and pulmonary artery pressure / echo response
- Methaemoglobin level with nitric oxide
- Platelet count / bleeding with prostacyclin
Management
- Consider as rescue for severe refractory hypoxaemia after prone positioning, recruitment and optimised PEEP
- Consider in acute right-ventricular failure or pulmonary hypertensive crisis to offload the RV
- Titrate to the oxygenation and pulmonary-pressure response and reassess — many patients are non-responders
- Wean slowly to avoid rebound pulmonary hypertension
- Monitor for agent-specific toxicity
Drugs & doses
Inhaled nitric oxide, or nebulised/inhaled prostacyclin (e.g. epoprostenol/iloprost)
Disposition
ICU rescue therapy alongside definitive management of the underlying cause.
Complications & pitfalls
- Rebound pulmonary hypertension
- Methaemoglobinaemia (nitric oxide)
- Platelet inhibition / hypotension (prostacyclin)
Exam pearls
- Improves oxygenation and pulmonary pressure but not survival in ARDS — a bridge, not definitive therapy
- Never stop abruptly — wean to prevent rebound pulmonary hypertension
- Check methaemoglobin when using nitric oxide
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.